본문 바로가기
KERD
논문KCI 등재

국한성 맥락막혈관종에서 발생한 장액망막박리에 대한 치료결과

Treatment Outcome of Serous Macular Detachment in Circumscribed Choroidal Hemangioma

4

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류안과학

초록

목적: 장액망막박리가 발생한 국한성 맥락막혈관종에서 항혈관내피성장인자 주사와 광역학치료 결과를 알아보고자 하였다. 대상과 방법: 국한성 맥락막혈관종 환자 중에서 황반부 장액망막박리가 발생하여 치료가 필요했던 환자들의 치료방법과 결과를 의무기록을 통해 후향적으로 조사하였다. 종양의 진단과 치료경과는 안저사진, 인도사이아닌그린 혈관조영술, 빛간섭단층촬영, 안초음파검사를 시행하여 분석하였다. 결과: 총 9명 9안을 치료 후 평균 19.2개월 동안 경과관찰하였다. 평균 시력은 0.51 ± 0.52 (logMAR), 종양의 최대지름은 평균 6,154.4 ± 2,019.9 μm, 두께는 평균 2,224.4 ± 862.1 μm였다. 첫 치료로 항혈관내피성장인자 유리체내주사를 받은 6안 중 5안은 평균 3.16회의 치료에 반응이 없거나 재발하여, 추가적인 광역학치료와 경동공온열치료가 필요하였다. 광역학치료를 받은 3안은 평균 1.3회의 치료 후 망막내/하액이 소실되고 재발은 없었다. 최종적으로 8안에서 완전한 망막내/하액의 소실을 얻을 수 있었으나, 평균시력은 치료 전과 차이가 없었다. 결론: 국한성 맥락막혈관종에서 발생한 장액망막박리에 대하여 항혈관내피성장인자 유리체내주사의 효과는 제한적이었으며, 광역학치료가 적은 치료횟수로 망막하액의 소실을 얻을 수 있었다.

Abstract

Purpose: To determine the clinical outcome of anti-vascular endothelial growth factor (anti-VEGF) and photodynamic therapy (PDT) for circumscribed choroidal hemangioma (CCH) with serous retinal detachment. Methods: The medical records of patients having CCH with serous retinal detachment in macula were retrospectively reviewed. CCH and serous retinal detachment were evaluated via fundus photography, optical coherence tomography, indocyanine green angiography, and ultrasonography. Results: A total of 9 eyes were enrolled in this study. The average follow-up period was 19.2 months. The mean visual acuity was 0.51 ± 0.52 (logMAR) and the mean maximum diameter and thickness of the tumor were 6,154.4 ± 2,019.9 μm and 2,224.4 ± 862.1 μm, respectively. Of the 6 eyes receiving anti-VEGF (mean number of injections: 3.16) as the first treatment for serous retinal detachment, 5 had sustained or recurred intraretinal/subretinal fluid (IRF/SRF) and needed additional PDT and transpupillary thermotherapy. In the 3 eyes that received PDT (mean number of treatments: 1.3) as an initial treatment, IRF/SRF was completely resolved. Finally, 8 eyes achieved complete resolution of SRF and IRF; however visual recovery was limited. Conclusions: PDT, even with a small number of treatments, can alleviate IRF/SRF in CCH, while anti-VEGF did not.

참고문헌 (31)

  1. Augsburger JJ, "Circumscribed choroidal hemangiomas: long-term visual prognosis", Retina, 1, pp.56~61 (1981)
  2. Chisholm IH, "Choroidal hemangioma, a diagnostic and therapeutic problem", Trans Ophthalmol Soc U K, 93, pp.161~169 (1973)
  3. Ferry AP, "Lesions mistaken for malignant melanoma of the posterior uvea. A clinicopathologic analysis of 100 cases with ophthalmoscopically visible lesions", Arch Ophthalmol, 72, pp.463~469 (1964)
  4. Gass JDM, "Differential Diagnosis of Intraocular Tumors: a Stereoscopic Presentation", pp.113~138 (1974), Mosby
  5. Kamal A, "Indocyanine green enhanced transpupillary thermotherapy of circumscribed choroidal haemangioma", Eye (Lond), 14(5), pp.701~705 (2000)
  6. Schmidt-Erfurth U, "Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration", Surv Ophthalmol, 45, pp.195~214 (2000)
  7. Witschel H, "Hemangioma of the choroid. A clinicopathologic study of 71 cases and a review of the literature", Surv Ophthalmol, 20, pp.415~431 (1976)
  8. Mashayekhi A, "Circumscribed choroidal hemangioma", Curr Opin Ophthalmol, 14, pp.142~149 (2003)
  9. Mandal S, "Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma", Indian J Ophthalmol, 59, pp.248~251 (2011)
  10. Vicuna-Kojchen J, "Application of the standard photodynamic treatment protocol for symptomatic circumscribed choroidal hemangioma", Ophthalmologica, 220, pp.351~355 (2006)
  11. Singh AD, "Photodynamic therapy of circumscribed choroidal haemangioma", Br J Ophthalmol, 88, pp.1414~1418 (2004)
  12. Gündüz K, "Transpupillary thermotherapy in the management of circumscribed choroidal hemangioma", Surv Ophthalmol, 49, pp.316~327 (2004)
  13. Kivelä T, "Stereotactic radiotherapy of symptomatic circumscribed choroidal hemangiomas", Ophthalmology, 110, pp.1977~1982 (2003)
  14. Sanborn GE, "Treatment of circumscribed choroidal hemangiomas", Ophthalmology, 89, pp.1374~1380 (1982)
  15. Ritland JS, "External beam irradiation therapy for choroidal haemangiomas. Visual and anatomical results after a dose of 20 to 25 Gy", Acta Ophthalmol Scand, 79, pp.184~186 (2001)
  16. Frau E, "Low-dose proton beam therapy for circumscribed choroidal hemangiomas", Arch Ophthalmol, 122, pp.1471~1475 (2004)
  17. Nicholson BP, "A review of clinical trials of anti-VEGF agents for diabetic retinopathy", Graefes Arch Clin Exp Ophthalmol, 248, pp.915~930 (2010)
  18. Noma H, "Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6", Am J Ophthalmol, 140, pp.256~261 (2005)
  19. Wang W, "VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly", Am J Physiol Heart Circ Physiol, 280, pp.H434~H440 (2001)
  20. Kenawy N, "Treatment of a vasoproliferative tumour with intravitreal bevacizumab (Avastin)", Eye (Lond), 21, pp.893~894 (2007)
  21. Kwon HJ, "Treatment of serous macular detachment associated with circumscribed choroidal hemangioma", Am J Ophthalmol, 154, pp.137~145 (2012)
  22. Soucek P, "Evaluation of subretinal fluid absorption by optical coherence tomography in circumscribed choroidal hemangioma after photodynamic therapy with verteporfin", Neuro Endocrinol Left, 25, pp.109~114 (2004)
  23. Barbazetto I, "Photodynamic therapy of choroidal hemangioma: two case reports", Graefes Arch Clin Exp Ophthalmol, 238, pp.214~221 (2000)
  24. Schmidt-Erfurth UM, "Photodynamic therapy for symptomatic choroidal hemangioma: visual and anatomic results", Ophthalmology, 109, pp.2284~2294 (2002)
  25. Porrini G, "Photodynamic therapy of circumscribed choroidal hemangioma", Ophthalmology, 110, pp.674~680 (2003)
  26. Jurklies B, "The role of photodynamic therapy in the treatment of symptomatic choroidal hemangioma", Graefes Arch Clin Exp Ophthalmol, 243, pp.393~396 (2005)
  27. Boixadera A, "Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma", Ophthalmology, 116, pp.100~105 (2009)
  28. Jurklies B, "Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma", Br J Ophthalmol, 87, pp.84~89 (2003)
  29. Verbraak FD, "Single spot PDT in patients with circumscribed haemangioma and near normal visual acuity", Graefes Arch Clin Exp Ophthalmol, 244, pp.1178~1182 (2006)
  30. 사공민, "Application of Intravitreal Bevacizumab for Circumscribed Choroidal Hemangioma", Korean Journal of Ophthalmology, 23(2), pp.127~131 (2009), 대한안과학회
  31. García-Arumí J, "Transpupillary thermotherapy for circumscribed choroidal hemangiomas", Ophthalmology, 107, pp.351~356 (2000)

관련 논문AI추천

이 간행물의 다른 논문 (19건)